key: cord-0711719-6np1uzky
authors: Clark, Lauren K.; Green, Todd J.; Petit, Chad M.
title: Structure of Nonstructural Protein 1 from SARS-CoV-2
date: 2021-01-28
journal: J Virol
DOI: 10.1128/jvi.02019-20
sha: 9ed92d88598d23507da8f21d4c68c0b922353499
doc_id: 711719
cord_uid: 6np1uzky

The periodic emergence of novel coronaviruses (CoVs) represents an ongoing public health concern with significant health and financial burdens worldwide. The most recent occurrence originated in the city of Wuhan, China, where a novel coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) emerged causing severe respiratory illness and pneumonia. The continual emergence of novel coronaviruses underscores the importance of developing effective vaccines as well as novel therapeutic options that target either viral functions or host factors recruited to support coronavirus replication. The CoV nonstructural protein 1 (nsp1) has been shown to promote cellular mRNA degradation, block host cell translation, and inhibit the innate immune response to virus infection. Interestingly, deletion of the nsp1-coding region in infectious clones prevented the virus from productively infecting cultured cells. Because of nsp1’s importance in the CoV life cycle, it has been highlighted as a viable target for both antiviral therapy and vaccine development. However, the fundamental molecular and structural mechanisms that underlie nsp1 function remain poorly understood, despite its critical role in the viral life cycle. Here, we report the high-resolution crystal structure of the amino globular portion of SARS-CoV-2 nsp1 (residues 10 to 127) at 1.77-Å resolution. A comparison of our structure with the SARS-CoV-1 nsp1 structure reveals how mutations alter the conformation of flexible loops, inducing the formation of novel secondary structural elements and new surface features. Paired with the recently published structure of the carboxyl end of nsp1 (residues 148 to 180), our results provide the groundwork for future studies focusing on SARS-CoV-2 nsp1 structure and function during the viral life cycle. IMPORTANCE Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the COVID-19 pandemic. One protein known to play a critical role in the coronavirus life cycle is nonstructural protein 1 (nsp1). As such, it has been highlighted in numerous studies as a target for both the development of antivirals and the design of live-attenuated vaccines. Here, we report the high-resolution crystal structure of nsp1 derived from SARS-CoV-2 at 1.77-Å resolution. This structure will facilitate future studies focusing on understanding the relationship between structure and function for nsp1. In turn, understanding these structure-function relationships will allow nsp1 to be fully exploited as a target for both antiviral development and vaccine design.

IMPORTANCE Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the COVID-19 pandemic. One protein known to play a critical role in the coronavirus life cycle is nonstructural protein 1 (nsp1). As such, it has been highlighted in numerous studies as a target for both the development of antivirals and the design of live-attenuated vaccines. Here, we report the high-resolution crystal structure of nsp1 derived from SARS-CoV-2 at 1.77-Å resolution. This structure will facilitate future studies focusing on understanding the relationship between structure and function for nsp1. In turn, understanding these structure-function relationships will allow nsp1 to be fully exploited as a target for both antiviral development and vaccine design.

KEYWORDS SARS-CoV-2, nonstructural protein 1, coronavirus, severe acute respiratory syndrome, X-ray crystallography, T he periodic emergence of novel coronaviruses (CoVs) represents an ongoing public health concern with significant health and financial burdens worldwide. In the past 2 decades, three highly pathogenic human CoVs have emerged from zoonotic events. In 2002, an outbreak of atypical pneumonia termed severe acute respiratory syndrome (SARS) appeared in the Guangdong Province of Southern China. The etiological agent with N-terminal truncations beginning at amino acid residue 10 continuing to residue 127. Both nsp1 constructs were expressed and purified to homogeneity.

Crystal Structure of nsp1 10-127 from SARS-CoV-2. Crystallization trials were initiated with nsp1 10-127 and nsp1 . Crystals were obtained with each construct, though the number of crystallization conditions was greater and crystal quality better with the longer construct, nsp1 . For this reason, structural studies were carried out with this construct. The structure of the globular domain of nsp1 was determined by molecular replacement with the core of SARS-CoV-1 nsp1 (PDB identifier [ID] 2HSX). Final data collection and refinement statistics are shown in Table 1 . The final model contained residues 10 to 126 (Fig. 1) . The tertiary fold of nsp1 is composed of regular secondary structural elements arranged sequentially as b1-h 1-a1-b2-h 3-b3-b4-b5-b6-b7 with h 1 and h 2 being 3 10 helices. A seven-stranded b-barrel is formed with a mixture of parallel and antiparallel b-strands with contacts between b2, b3, b4, b5, and b6 strands as well as b1 and b7 strands. The b-strands consist of residues 13 to 20 (b1), 51 to 54 (b2), 68 to 73 (b3), 84 to 92 (b4), 95 to 97 (b5), 103 to 109 (b6), and 117 to 123 (b7). The h 1 (residues 23 to 25) and h 2 (residues 61 to 63) helices are positioned across one barrel opening, while a1 (residues 34 to 49) is positioned alongside the barrel making contact with the b4 strand. 

is the i-th measurement of reflection hkl, [I(hkl)] is the weighted mean of all measurements, and N is the redundancy for the hkl reflection. d R work /R free = R hkl jF o 2 F c j/R hkl jF o j, where F c is the calculated and F o is the observed structure factor amplitude of reflection hkl for the working/free set, respectively; 10% of reflections were reserved for the R free set. e RMS, root mean square.

Comparison with solution structure of nsp1 13-127 from SARS-CoV-1. The nsp1 portion of ORF1ab is well conserved when comparing SARS-CoV-1 and SARS-CoV-2 (84% identity) ( Fig. 2A ). This relatively high conservation is also applicable to the subset of amino acids (10 to 126) that comprise our structure (86%). This level of conservation between CoVs is remarkable given the limited amino acid sequence homology among nsp1s from different b-CoVs (19) . A number of mutations (9 of 16) occur in the large loops in the structure (Fig. 2B) . It is widely understood that loops often play critical roles in protein-protein interactions, making these mutations particularly interesting (24, 25) .

We note that the structure is composed of approximately the same portions of nsp1 (residues 10 to 127) as the previously solved nsp1 structure from SARS-CoV-1 (residues 13 to 127). The fold of SARS-CoV-2 nsp1 is generally well conserved compared to the previously solved structure of nsp1 from SARS-CoV-1 (Fig. 2C) . However, there are several notable differences between the structures upon detailed analysis. One such difference is the presence of an additional 3 10 helix (h 1) in the SARS-CoV-2 structure (residues 23 to 25). We note that the primary sequence composing this additional 3 10 helix is identical between SARS-CoV-1 and SARS-CoV-2. Additionally, there are no apparent proximal mutations in SARS-CoV-2 that would stabilize this 3 10 helix. The stabilization of this helix is due to a polar interaction between R24 in a1 and Q63 in a3

In addition to the formation of a new 3 10 helix in nsp1 from SARS-CoV-2, there are also mutations that result in extension of b-strands within the interior of the protein when comparing the two proteins. The b4 strand is extended by four amino acids and is now composed by amino acids 84 to 92 in SARS-CoV-2 as opposed to amino acids 87 to 91 in SARS-CoV-1. This is due to the K84V, V85M, and M92L mutations in positions adjacent to the b4 strand (Fig. 3B ). This extension facilitates the formation of a new b-strand (b5) not found in the original SARS-CoV-1 structure. This strand is composed of amino acids 95 to 97 and is stabilized by main chain contacts with residues 90 to 92 (Fig. 3C ). The b6 strand is also extended by two amino acids, and so it is now composed of amino acids 103 to 109 rather than amino acids 105 to 109. This extension is due to additional main chain interactions. Finally, b1, b3, and b6 (b5 in SARS-CoV-1) strands are also extended by a single amino acid.

One striking difference between the structures is the alternative conformations of two major loops located between b3 and b4 (loop 1) and between b4 and b6 (loop 2, b4 and b5 in SARS-CoV-1) (Fig. 4) . The residues that make up these loops in SARS-CoV-2 nsp1 form a much more significant network of polar contacts with respect to those in the analogous loops in SARS-CoV-1 nsp1. These changes in local stability and conformation facilitate the formation of a new b-strand (b5) not found in SARS-CoV-1 nsp1. Analyses of loop 1 (residues 73 to 84) and loop 2 (residues 92 to 104) indicate average C a displacements of 16.6 Å and 27.6 Å, respectively. As loops play critical roles in 

Journal of Virology protein-protein interactions, relative variations in these loops between SARS-CoV-1 and SARS-CoV-2 are particularly interesting as they may alter host-pathogen interactions involving nsp1 (24, 25) . Structural differences between the two proteins result in differences in the electrostatic surface potential. These differences are the result of conformational differences and mutations presented on the surfaces of the proteins. Figure 5 contrasts four of these regions. Both SARS-CoV-1 and SARS-CoV-2 nsp1 share a large common patch of electronegative potential (Fig. 5A and E) ; however, in SARS-CoV-2 nsp1, the electronegative surface potential has an increased intensity and clustering has increased. This patch in SARS-CoV-2 nsp1 is generated by D33, E36, E37, E41, Q44, H45, D48, E65, Q66, and E93. These residues comprise three mutations from SARS-CoV-1 nsp1 and include E44Q, N48D, and D93E. In addition, a valley between the upper and lower portions of the patch in SARS-CoV-1 residues, between residues D33 and E65, is closed in SARS-CoV-2 by the reorientation of the main chain flanking Q66. This reorientation allows the sidechain of Q66 to form a new hydrogen bond with the amide nitrogen of E93. A dominant electropositive pocket and extended surface is also observed in both struc- tures ( Fig. 5B and F) . In SARS-CoV-2 nsp1, this region is composed of K11, R43, K47, R77, R124, and K125. The contiguous pit of electronegativity observed in SARS-CoV-2 nsp1 is disrupted in the SARS-CoV-1 structure by rearrangement of the C terminus allowing G127 to protrude between R43 and K125. Two smaller juxtaposed electropositive and electronegative patches are shown in Fig. 5C and G. There are three mutations relative to SARS-CoV-1 nsp1 in this area: K84V, I102E, and N120K. In the SARS-CoV-2 structure, two mutations contribute to the negative surface character of this region. The mutated side chain of V84 occupies the space of K84 in SARS-CoV-1, while K120 buttresses the bottom of the patch. In the adjacent electropositive patch, E102 sits in the positive pocket surrounded by E55, E57, and E102. The conformation of the loop between b3 and b4, as well as the restructured strand (b5) and loop between b4 and b6 (b4 and b5 in SARS-CoV-1), contributes to vastly different surface contours (Fig. 5C and G) . Finally, a new electronegative crevasse is generated by the restructuring of strand b5 and the trailing loop leading to strand b6 and subsequent reposition of the concluding residues of b7 through the C terminus (residues 122 to 126) in SARS-CoV-2 ( Fig. 5D and H) . Two prominent residues in this new crevasse are D75 and E87. These residues are identical in SARS-CoV-1; however, the surrounding residues are positioned so that they are more obscured from the surface. E87 (SARS-CoV-1) is sandwiched between K72 and R124, appearing to salt bridge with K72.

Structural homology between SARS-CoV-2 nsp1 and a-CoV nsp1s. The structures of SARS-CoV-1 nsp1 and SARS-CoV -2 nsp1 represent the known nsp1 structures of b-CoVs. To date, the structures of five additional nsp1 structures originating from viruses in the a-coronavirus genera have been published. The sequence identity between SARS-CoV-2 nsp1 and these a-CoV nsp1s is extremely low at 9% to 13%, with only marginally more sequence similarity at 21% to 27%. There is, however, easily identifiable structural homology between nsp1s derived from aand b-CoVs. The structure of SARS-CoV-2 was structurally aligned with the structures of nsp1s from porcine transmissible gastroenteritis coronavirus strain Purdue (3ZBD) (26) , porcine epidemic diarrhea virus (5XBC) (27) , transmissible gastroenteritis virus (6IVC) (28) , swine acute diarrhea syndrome coronavirus (6LPA) (29) , and feline infectious peritonitis virus (6LP9) (29) . Aligned structures are illustrated in Fig. 6 , with statistical analysis data compiled in Table 2 . All of the structures share a core topological similarity. However, there are substitutions and insertions in the linear arrangement of the secondary structure elements (Fig. 6C ). The first 3 10 helix of the SARS-CoV-2 structure is swapped for strand b2 in the a-CoV structures, though essentially occupying the same space. Strand b4 represents an insertion in the a-CoV structures. The strand forms a short parallel b-strand configuration with b2. As noted above, SARS-CoV-2 has a new strand b5, not observed in SARS-CoV-1. This strand is also a deviation from the topology of the a-CoV nsp1 structures. The rest of the secondary structural elements follow a common fold and alignment, being b1-a1-b2-h 2-b3-b4-b6-b7 for SARS-CoV-2 and b1-a1-b3-h 1-b5-b6-b7-b8 for a-CoVs (Fig. 6H) .

Here, we report the high-resolution structure of nsp1 derived from SARS-CoV-2, the etiological agent of COVID-19. The interior of the protein is composed of a sevenstranded b-barrel with an a-helix positioned on the side of the barrel and two 3 10 helices across one end of the barrel. nsp1 is highly homologous to SARS-CoV-1 nsp1 in both structure and sequence. However, there are a number of differences between the two proteins that may alter their function in the context of their respective viral life cycles. One difference is the presence of secondary structural elements, an additional b-strand (b5) and 3 10 helix, in SARS-CoV-2 nsp1 that are not in SARS-CoV-1 nsp1. Several of the major loops in SARS-CoV-2 nsp1 are also in alternative conformations due to the increased polar contacts between amino acids that compose them and the globular domain. Finally, there are differences in the electrostatic surface potential resulting from amino acid differences between the two proteins. Given the critical role that nsp1 plays in the CoV life cycle, these differences may underlie fundamental differences between the SARS-CoV-2 and SARS-CoV-2 such as virulence, pathogenicity, and infectivity.

nsp1 is a virulence determinant of CoVs that plays critical roles during the viral life cycle such as suppressing host gene expression (14, 30, 31) . This suppression of host gene expression is necessary for viral replication and allows evasion of the cellular immune response. In a recent study, cryo-electron microscopy (cryo-EM) was used to show that the carboxyl terminus (residues 148 to 180) of SARS-CoV-2 nsp1 binds to the 40S ribosomal subunit and inhibits translation (32, 33) . Specifically, the structures revealed that this fragment of nsp1 binds to the mRNA entry channel of the 40S subunit, which effectively blocks translation (32, 33) . We modeled the structure of fulllength nsp1 using the I-TASSER platform with our structure as a template (34) (35) (36) . As shown in Fig. 7 , residues 1 to 9 and 131 to 162 contain no discernible secondary structure, with the remaining residues adopting two a-helices. This is compatible with the cryo-EM structure that indicates that the carboxyl terminus (residues 148 to 180) binds to the 40S ribosomal subunit (32, 33) . Additionally, there is a high degree of structural and sequence homology between nsp1 derived from SARS-CoV-1 and from SARS-CoV-2. The rare conservation among different b-CoVs may provide insight into SARS-CoV-2 nsp1 function from previous studies that focused on SARS-CoV-1 nsp1 (19) . For example, previous studies have shown that nsp1 from SARS-CoV-1 is unique among CoVs and is hypothesized to contribute to the exceptional pathogenesis of SARS-CoV-1 in humans (37, 38) . In fact, nsp1 control of interferon expression may be crucial to SARS-CoV-1 infection given that the virus is interferon sensitive (15, 39, 40) . Further studies will be needed to determine which functions are common between the two proteins and if there are any functional differences that alter their respective viral lifecycles.

There is an urgent need to develop both vaccines and antivirals against SARS-CoV-2 and any potential novel CoVs that pose a threat to global health. Because of its critical role, nsp1 has been identified as a target for both the development of broad-spectrum antivirals and rational live-attenuated vaccine design (19, 20, (41) (42) (43) (44) (45) (46) (47) . This fact was underscored by a previous study that focused on the function of nsp1 during the SARS-CoV-1 life cycle which concluded the following. "How SARS-CoV nsp1 functions remains to be answered. Removal of the nsp1 protein function from the virus (48) will enable determination of its effects on replication and/or virulence in vivo; however, these experiments will require careful design and analysis because indiscriminate deletion of nsp1 sequence would remove cis-acting elements required for replication" (49) . This conclusion is even more relevant during the COVID-19 pandemic. Our findings, combined with the structures of the carboxyl end of nsp1, are the first step to a comprehensive understanding of the structure-function relationship of SARS-CoV-2 nsp1.

Note that during the preparation of the manuscript, an independent X-ray crystal structure of SARS-CoV-2 nsp1 was deposited in PDB (ID 7K3N). The two structures, PDB ID 7K7P (this work) and 7K3N, have an RMSD of 0.351 Å based on C a positioning, indicating that they are highly correlated.

Protein expression and purification. The nsp1 segment of SARS-CoV-2 was subcloned into a 6Â His-SMT3 fusion T7 expression vector (pE-SUMO; Life Sensors) using primers to amplify residues 10 to 127 of ORF1a. Expression plasmids were transformed into DE3 Star BL21 Escherichia coli cells and grown in LB medium containing 200 mg/ml of kanamycin. The nsp1 cultures were induced at an optical density at 600 nm (OD 600 ) of 0.7 with 1 mM isopropyl b-D-1-thiogalactopyranoside for 48 h at 18°C. Cells were lysed via sonication in buffer containing 20 mM HEPES, 500 mM NaCl, 5 mM imidazole, 5 mM dithiothreitol (DTT), and 1.3 mg/ml lysozyme at pH 7.8. Clarified lysates were loaded onto a His tag purification column (Roche), and the protein was eluted in a buffer containing 20 mM HEPES, 500 mM NaCl, 250 mM imidazole, and 2.5 mM DTT at pH 8. The 6Â His-SMT3 tag was removed from the N terminus with recombinant SUMO protease. The cleaved sample was then reloaded onto the His tag purification column to separate the 6Â His-SMT3 tag from nsp1. Buffer exchange was performed with size exclusion chromatography using a Hi-Prep 26/60 Sephacryl S-100 HR (GE). The final buffer is composed of 20 mM NaPO 4 , 200 mM NaCl, 1 mM EDTA, 50 mM arginine, 50 mM glutamic acid, and 0.02% sodium azide at pH 6.8.

Crystallization, data collection, structure determination, and refinement. Purified SARS-CoV-2 nsp1 was concentrated to 7 mg/ml and screened for crystallization conditions against commercially available kits using a Mosquito liquid handling robot (SPT Labtech). Diffraction quality crystals were obtained under conditions from multiple kits. An initial X-ray diffraction data set was collected with the Pilatus 200K detector (Dectris) atop a MicroMax-007 HF rotating anode X-ray generator (Rigaku) from a crystal grown in 0.1 M morpholineethanesulfonic acid (MES) monohydrate (pH 6.5) and 12% (wt/vol) polyethylene glycol 20000 and cryoprotected with a supplement of 20% glycerol. Raw intensity data were processed with the HKL3000 package (50) . Initial phases were solved by molecular replacement with Phaser (51) using the core structure of PDB ID 2HSX. The structure was initially traced and refined with the Autobuild routine in PHENIX (52), followed by manual editing in Coot (53) and refinement with phenix.refine. This nearly complete model was used as the model for molecular replacement with a final high-resolution data set collected from a crystal grown in 0.2 M sodium acetate trihydrate, 0.1 M sodium cacodylate trihydrate (pH 6.5), and 30% (wt/vol) polyethylene glycol 8000 and cryoprotected with a supplement of 20% glycerol. The model was further traced manually and refined with phenix.refine. Data collection and refinement statistics are displayed in Table 1 . All ribbon and surface illustrations of protein structures were prepared with PyMOL (Schrödinger) (54) . Alignment statistics were determined with structure alignment tools from the RCSB (55) .

Data availability. Structure factors and final refined coordinates have been deposited in the PDB with accession code 7K7P.

Severe acute respiratory syndrome: identification of the etiological agent

A novel coronavirus associated with severe acute respiratory syndrome

The severe acute respiratory syndrome

MERS coronavirus outbreak: implications for emerging viral infections

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Programmed ribosomal frameshifting in decoding the SARS-CoV genome

Characterization of an efficient coronavirus ribosomal frameshifting signal: requirement for an RNA pseudoknot

Virus-encoded proteinases and proteolytic processing in the Nidovirales

A contemporary view of coronavirus transcription

The coronavirus replicase

SARS coronavirus nsp1 protein induces template-dependent endonucleolytic cleavage of mRNAs: viral mRNAs are resistant to nsp1-induced RNA cleavage

Alphacoronavirus transmissible gastroenteritis virus nsp1 protein suppresses protein translation in mammalian cells and in cell-free HeLa cell extracts but not in rabbit reticulocyte lysate

A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein

Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation

Attenuation of mouse hepatitis virus by deletion of the LLRKxGxKG region of Nsp1

Severe acute respiratory syndrome coronavirus protein nsp1 is a novel eukaryotic translation inhibitor that represses multiple steps of translation initiation

Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells

Coronavirus nonstructural protein 1: common and distinct functions in the regulation of host and viral gene expression

Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines

Mutagenesis of the murine hepatitis virus nsp1-coding region identifies residues important for protein processing, viral RNA synthesis, and viral replication

A point mutation within the replicase gene differentially affects coronavirus genome versus minigenome replication

Novel beta-barrel fold in the nuclear magnetic resonance structure of the replicase nonstructural protein 1 from the severe acute respiratory syndrome coronavirus

Comprehensive analysis of loops at protein-protein interfaces for macrocycle design

Analysis of loops that mediate protein-protein interactions and translation into submicromolar inhibitors

Structure of alphacoronavirus transmissible gastroenteritis virus nsp1 has implications for coronavirus nsp1 function and evolution

Structural basis for the inhibition of host gene expression by porcine epidemic diarrhea virus nsp1

A conserved region of nonstructural protein 1 from alphacoronaviruses inhibits host gene expression and is critical for viral virulence

Structural and biological basis of alphacoronavirus nsp1 associated with host proliferation and immune evasion

Identification of the mechanisms causing reversion to virulence in an attenuated SARS-CoV for the design of a genetically stable vaccine

Severe acute respiratory syndrome coronavirus nsp1 facilitates efficient propagation in cells through a specific translational shutoff of host mRNA

Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2

SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation

I-TASSER: a unified platform for automated protein structure and function prediction

The I-TASSER Suite: protein structure and function prediction

Protein structure and function prediction using I-TASSER

SARS-beginning to understand a new virus

Severe acute respiratory syndrome (SARS): a year in review

Treatment of SARS with human interferons

The antiviral effect of interferon-beta against SARS-coronavirus is not mediated by MxA protein

Human coronavirus NL63 replication is cyclophilin A-dependent and inhibited by non-immunosuppressive cyclosporine A-derivatives including alisporivir

Cyclophilin A: a key factor in virus replication and potential target for anti-viral therapy

Cyclophilins and cyclophilin inhibitors in nidovirus replication

The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors

Suppression of coronavirus replication by cyclophilin inhibitors

Coronaviruses -drug discovery and therapeutic options

Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain

Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus

Unique SARS-CoV protein nsp1: bioinformatics, biochemistry and potential effects on virulence

Processing of X-ray diffraction data collected in oscillation mode

Phaser crystallographic software

PHENIX: a comprehensive Python-based system for macromolecular structure solution

Features and SARS-CoV-2 nsp1 Structure Journal of Virology development of Coot

The PyMOL molecular graphics system, version 2.0. Schrodinger, LLC

RCSB Protein Data Bank: biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy

This work was funded by the National Institutes of Health grants AI134693 (C.M.P.) and AI116738 (T.J.G.) in addition to the UAB School of Medicine and Hugh Kaul Precision Medicine Institute Urgent COVID-19 Research Award (C.M.P.). The O'Neal Comprehensive Cancer's X-ray crystallography core facility is supported through NIH P30CA13148.